Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 36.92 USD 1.9% Market Closed
Market Cap: 751m USD

Profitability Summary

Nektar Therapeutics's profitability score is 19/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score
19/100
Profitability
Score

Margins

Earnings Waterfall
Nektar Therapeutics

Margins Comparison
Nektar Therapeutics Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Nektar Therapeutics
NASDAQ:NKTR
725.6m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Nektar Therapeutics Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Nektar Therapeutics
NASDAQ:NKTR
725.6m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Nektar Therapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate